MATRIX-DPRS: Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System

Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Completed
CT.gov ID
NCT03076853
Collaborator
(none)
511
1
2.9
176.7

Study Details

Study Description

Brief Summary

The aim of MATRIX-DPRS is to assess the clinical and organizational impacts of the use of the medication record, opened, filled and managed by pharmacists (from private office and hospital units) by hospital physicians in private and public healthcare establishments (volunteers), for three clinical contexts: anaesthesiology visit before surgery, medications abuse and emergency hospitalization, medications and elderly hospitalisations.

Condition or Disease Intervention/Treatment Phase
  • Other: Opening of the Pharmaceutical Record

Detailed Description

As part of the national 2012 PREPS call for proposals, a multidisciplinary research team was set up to design and develop methods in order to evaluate the efficiency and the performance of health data information systems. This team is composed of physicians and researchers in medical informatics, hospital information systems, biostatistics, process analysis and management in healthcare, ergonomics and usability. This study was aimed to evaluate the clinical and organizational impacts of the use of a new source of information brought by the pharmaceutical record, promoted by the national committee of pharmacists. This record is opened and filled for each patient by the pharmacist. It contains all the medication sold (prescribed by physician and OTC) by the patient. This record is used by almost all the private pharmacists. The French Health Ministry was looking for an evaluation of this new source of information by hospital physicians in order to be applied by any healthcare institution or organization wishing to evaluate the added value of its investments or recommendations (example: ARS (French Regional Health Agency), DGOS (French Directorate General of Health Services), etc.) in the information system.

Study Design

Study Type:
Observational
Actual Enrollment :
511 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Medication Assessment Through Real Time Information eXchange - Distributed Pharmaceutical Record System
Actual Study Start Date :
Apr 3, 2016
Actual Primary Completion Date :
Jun 30, 2016
Actual Study Completion Date :
Jun 30, 2016

Arms and Interventions

Arm Intervention/Treatment
Patients with Pharmaceutical Record

Other: Opening of the Pharmaceutical Record
After a first prescription without the pharmaceutical record, the study investigator has to open the pharmaceutical record to obtain some additional data. After, he has to choose between maintain or modify his first prescription.

Outcome Measures

Primary Outcome Measures

  1. Modification of the medical prescription linked to the use of the pharmaceutical record [3 months]

    The primary outcome measure is to evaluate the impact of the use of the pharmaceutical record on th medical prescription. The doctor writes a first medical prescription without using the pharmaceutical record and a second with the pharmaceutical record.The changes are analyzed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Concerning Anesthesia department:
  • Patients in pre-anesthesia consultation for scheduled intervention.
Concerning Emergencies department:
  • Patients admitted for fainting fit
Regarding patients hospitalized in geriatrics:
  • Patients admitted to geriatrics
Exclusion Criteria:
  • Minors

  • Patients without administrative or judicial freedom if the authorization of the legal representative can not be collected.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Nice Nice France 06000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nice

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT03076853
Other Study ID Numbers:
  • 13-PREPS-01
First Posted:
Mar 10, 2017
Last Update Posted:
Mar 10, 2017
Last Verified:
Mar 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 10, 2017